Your browser doesn't support javascript.
loading
Genome-wide association meta-analysis yields 20 loci associated with gallstone disease.
Ferkingstad, Egil; Oddsson, Asmundur; Gretarsdottir, Solveig; Benonisdottir, Stefania; Thorleifsson, Gudmar; Deaton, Aimee M; Jonsson, Stefan; Stefansson, Olafur A; Norddahl, Gudmundur L; Zink, Florian; Arnadottir, Gudny A; Gunnarsson, Bjarni; Halldorsson, Gisli H; Helgadottir, Anna; Jensson, Brynjar O; Kristjansson, Ragnar P; Sveinbjornsson, Gardar; Sverrisson, David A; Masson, Gisli; Olafsson, Isleifur; Eyjolfsson, Gudmundur I; Sigurdardottir, Olof; Holm, Hilma; Jonsdottir, Ingileif; Olafsson, Sigurdur; Steingrimsdottir, Thora; Rafnar, Thorunn; Bjornsson, Einar S; Thorsteinsdottir, Unnur; Gudbjartsson, Daniel F; Sulem, Patrick; Stefansson, Kari.
Afiliação
  • Ferkingstad E; deCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
  • Oddsson A; deCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
  • Gretarsdottir S; deCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
  • Benonisdottir S; deCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
  • Thorleifsson G; deCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
  • Deaton AM; deCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
  • Jonsson S; deCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
  • Stefansson OA; deCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
  • Norddahl GL; deCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
  • Zink F; deCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
  • Arnadottir GA; deCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
  • Gunnarsson B; deCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
  • Halldorsson GH; deCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
  • Helgadottir A; deCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
  • Jensson BO; deCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
  • Kristjansson RP; deCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
  • Sveinbjornsson G; deCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
  • Sverrisson DA; deCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
  • Masson G; deCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
  • Olafsson I; Department of Clinical Biochemistry, Landspítali University Hospital, Reykjavik, 101, Iceland.
  • Eyjolfsson GI; Laboratory in Mjódd (RAM), Reykjavik, 109, Iceland.
  • Sigurdardottir O; Department of Clinical Biochemistry, Akureyri Hospital, Akureyri, 600, Iceland.
  • Holm H; deCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
  • Jonsdottir I; deCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
  • Olafsson S; Faculty of Medicine, University of Iceland, Reykjavik, 101, Iceland.
  • Steingrimsdottir T; Department of Immunology, Landspitali University Hospital, Reykjavik, 101, Iceland.
  • Rafnar T; Department of Internal Medicine, Landspitali University Hospital, Reykjavik, 101, Iceland.
  • Bjornsson ES; Faculty of Medicine, University of Iceland, Reykjavik, 101, Iceland.
  • Thorsteinsdottir U; Department of Obstetrics and Gynecology, Landspitali University Hospital, Reykjavik, 101, Iceland.
  • Gudbjartsson DF; deCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
  • Sulem P; Faculty of Medicine, University of Iceland, Reykjavik, 101, Iceland.
  • Stefansson K; Department of Internal Medicine, Landspitali University Hospital, Reykjavik, 101, Iceland.
Nat Commun ; 9(1): 5101, 2018 11 30.
Article em En | MEDLINE | ID: mdl-30504769
ABSTRACT
Gallstones are responsible for one of the most common diseases in the Western world and are commonly treated with cholecystectomy. We perform a meta-analysis of two genome-wide association studies of gallstone disease in Iceland and the UK, totaling 27,174 cases and 736,838 controls, uncovering 21 novel gallstone-associated variants at 20 loci. Two distinct low frequency missense variants in SLC10A2, encoding the apical sodium-dependent bile acid transporter (ASBT), associate with an increased risk of gallstone disease (Pro290Ser OR = 1.36 [1.25-1.49], P = 2.1 × 10-12, MAF = 1%; Val98Ile OR = 1.15 [1.10-1.20], P = 1.8 × 10-10, MAF = 4%). We demonstrate that lower bile acid transport by ASBT is accompanied by greater risk of gallstone disease and highlight the role of the intestinal compartment of the enterohepatic circulation of bile acids in gallstone disease susceptibility. Additionally, two low frequency missense variants in SERPINA1 and HNF4A and 17 common variants represent novel associations with gallstone disease.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cálculos Biliares / Estudo de Associação Genômica Ampla Tipo de estudo: Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cálculos Biliares / Estudo de Associação Genômica Ampla Tipo de estudo: Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article